Azienda Ospedaliera di Padova

Neuromuscular disease and peripheral neuropathy

Clinical research includes anti-MAG neuropathy and Spinal and Bulbar Muscular Atrophy (SBMA), with attention to functional disability, sensory impairment, and motor weakness.

  • Peripheral anti-MAG neuropathy
  • Spinal and Bulbar Muscular Atrophy
  • Neurological function and disability assessment

The sponsored studies reflect interest in disorders affecting peripheral nerves and motor neuron-related function.

Haematological malignancies and B-cell disorders

Research activity extends to Waldenström macroglobulinemia, marginal zone lymphoma, chronic lymphocytic leukemia, and monoclonal gammopathy of unknown significance.

  • Waldenström macroglobulinemia
  • Marginal zone lymphoma
  • Chronic lymphocytic leukemia
  • Monoclonal gammopathy of unknown significance

These trials indicate a focus on lymphoproliferative and plasma cell-related conditions with neurological overlap.

Hepatology and advanced liver disease

Trials also address decompensated liver cirrhosis, with emphasis on safety and clinical management in patients with severe hepatic impairment.

  • Decompensated liver cirrhosis
  • Hepatic decompensation
  • Liver-related clinical care

This area highlights interest in complex cirrhosis care and treatment options for advanced liver dysfunction.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A Study of Zanubrutinib for Patients with Anti-MAG Antibody Neuropathy Associated with Blood Disorders or Abnormal Protein in the Blood

    Recruiting

    1 1 1
    Investigated drugs:
    Italy
  • Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Recruiting

    1 1
    Investigated drugs:
    Italy
  • Study on Dapagliflozin for Patients with Decompensated Liver Cirrhosis

    Recruiting

    1 1 1
    Investigated drugs:
    Italy